Inspection History

Since 2014, Sinopep’s GMP manufacturing facilities have successfully passed four (4) inspections conducted by the U.S. FDA, demonstrating our strong commitment to global regulatory compliance and product quality. In addition to these FDA audits, Sinopep has also undergone inspections by the Korean MFDS and has successfully completed 20 regulatory audits conducted by the NMPA in China.
Date Inspected Product Inspection Type Result
Apr 2014 Peptide API FDA CCMP Pass
Apr 2016 Peptide API FDA CCMP Pass
Jan 2019 Routine Inspection FDA CCMP Pass
Nov 2023 Small Molecule & Peptide API MFDS CCMP Pass
Sep 2024 Routine Inspection (Unannounced Inspection) FDA CGMP Pass
July 2025 Semaglutide & Liraglutide ANVISA CGMP Pass